Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jul;9(7):409-12.
doi: 10.1097/gim.0b013e3180986e05.

The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1

David A Stevenson  1 , David H Viskochil, Elizabeth K Schorry, Alvin H Crawford, Jacques D'Astous, Kathleen A Murray, J M Friedman, Linlea Armstrong, John C Carey
Affiliations
Review

The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1

David A Stevenson et al. Genet Med. 2007 Jul.

Abstract

Neurofibromatosis type 1 is diagnosed clinically based on the presence of two of seven criteria developed by a panel of experts in 1987. The sixth criterion focuses on skeletal findings and is as follows: "A distinctive osseous lesion such as sphenoid dysplasia or thinning of long bone cortex, with or without pseudarthrosis." The wording for this criterion is misleading. In particular, "thinning of long bone cortex" is not the characteristic radiographic presentation, and no mention of long bone bowing is included. The distinctive clinical feature of long bone dysplasia in neurofibromatosis type 1 is anterolateral bowing of the lower leg (portion of the body delimited by the knee and ankle). The usual radiographic findings of long bone dysplasia in neurofibromatosis type 1 at first presentation, prior to fracture, are anterolateral bowing with medullary canal narrowing and cortical thickening at the apex of the bowing. We suggest that anterolateral bowing of the lower leg, with or without fracture or pseudarthrosis, is a more appropriate description of the primary finding that a clinician will use to fulfill the sixth diagnostic criterion for neurofibromatosis type 1. Clarification of this diagnostic criterion is important for the clinician and for research protocols. Appropriate interpretation will improve understanding of the natural history and pathophysiology of neurofibromatosis type 1.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Radiographs of the lower leg (both AP and lateral views) demonstrating anterolateral bowing of the tibia with cortical thickening (A,B,C).
Fig. 1
Fig. 1
Radiographs of the lower leg (both AP and lateral views) demonstrating anterolateral bowing of the tibia with cortical thickening (A,B,C).
Fig. 1
Fig. 1
Radiographs of the lower leg (both AP and lateral views) demonstrating anterolateral bowing of the tibia with cortical thickening (A,B,C).
See this image and copyright information in PMC

References

    1. Neurofibromatosis Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575–578. - PubMed
    1. Gutmann DH, Aylsworth A, Carey JC, Korf B, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278:51–57. - PubMed
    1. Friedman JM, Birch PH. Type 1 Neurofibromatosis: A descriptive analysis of the disorder in 1728 patients. Am J Med Genet. 1997;70:138–143. - PubMed
    1. Crawford AH, Schorry EK. Neurofibromatosis in children; the role of the orthopaedist. J Am Academy of Orthopaedic Surgeons. 1999;7:217–230. - PubMed
    1. Crawford AH, Schorry EK. Neurofibromatosis update. J Pediatr Orthop. 2006;26:413–23. - PubMed

Publication types

MeSH terms